Quantcast
Last updated on April 18, 2014 at 16:16 EDT

Latest Psychopharmacology Stories

2014-02-21 23:03:33

Drug Allgedly Linked to Breast Enlargement in Males DALLAS (PRWEB) February 21, 2014 The national plaintiffs’ law firm of Baron and Budd announces that it is now handling lawsuits relative to the drug Risperdal. Risperdal is prescribed to treat children, adolescents and adults with schizophrenia. Baron and Budd lawyers are working with males who allegedly suffered breast enlargement after taking the drug. Risperdal, manufactured by Johnson & Johnson, was first approved by the Food...

2013-12-12 08:31:06

Sundance Diagnostics and the Max Planck Institute of Psychiatry Agree on Global License for Commercialization BOULDER, Colo., Dec. 12, 2013 /PRNewswire/ -- Sundance Diagnostics announces they have entered into an exclusive, worldwide licensing agreement with the Max Planck Institute of Psychiatry, Munich, Germany, to expand the Institute's initial clinical validation of genetic markers and to commercialize a genetic test that predicts risk of suicide emerging from use of...

2013-11-07 12:47:15

Rutgers study could lead to a better understanding of human addiction – alcohol, tobacco and food – as well as substance abuse Cocaine addicts may become trapped in drug binges – not because of the euphoric highs they are chasing but rather the unbearable emotional lows they desperately want to avoid. In a study published today online in Psychopharmacology, Rutgers University Behavioral and Systems Neuroscience Professor Mark West, and doctoral student David Barker in the...

2013-10-28 16:24:42

Professor Bankole A. Johnson, Chairman of Psychiatry at the University of Maryland School of Medicine, Reports Latest Findings on the Anti-epileptic Drug, Topiramate BALTIMORE, Oct. 28, 2013 /PRNewswire-USNewswire/ -- New research published in JAMA Psychiatry reveals that topiramate, a drug approved by the U.S. Food and Drug Administration (FDA) to treat epilepsy and migraine headaches, also could be the first reliable medication to help treat cocaine dependence. The study,...

2013-09-16 12:26:04

Partnership combines Pharmacology Corner and Psychopharmacology Institute with the leading industry reach and resources of UBM Medica US NORWALK, Conn., Sept. 16, 2013 /PRNewswire/ -- Pharmacology Corner and Psychopharmacology Institute today announced a unique marketing and distribution partnership with UBM Medica US. Pharmacology Corner is a multi-specialty resource for pharmacists and other medical professionals, and Psychopharmacology Institute focuses on delivering content to the field...

Experimental Cocaine Vaccine Effective On Mice, Primates
2013-05-11 09:39:58

Brett Smith for redOrbit.com — Your Universe Online Although trends are pointing to a decrease in recent years, cocaine use is still a major problem in the US, with 1.5 million users in 2010 — according to the Substance Abuse and Mental Health Services Administration (SAMHSA). To combat this highly addictive illegal drug, researchers at Weill Cornell Medical College are developing an “anti-cocaine vaccine” designed to keep the drug from creating the...

2012-12-06 08:26:22

HOLLYWOOD, Fla. and EVANSTON, Ill., Dec. 6, 2012 /PRNewswire/ -- Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported positive results from a Phase IIa clinical trial of its lead antidepressant compound, GLYX-13. GLYX-13 is a novel partial agonist of the NMDA receptor. The Phase Ila results are being presented this week at the 51(st) Annual Meeting of the American College of Neuropsychopharmacology (ACNP)....

2012-05-23 18:52:13

Fresh guidelines on the best methods to treat substance abuse and addiction The British Association for Psychopharmacology (BAP) has released fresh guidelines on the best methods to treat substance abuse and addiction in the Journal of Psychopharmacology, published by SAGE. A panel of experts has carefully researched the new, comprehensive guidelines, offering practitioners a detailed review of the evidence to help them optimize their clinical decisions. The new BAP guidelines target...

2012-05-22 21:47:44

Patient care nationwide may be affected when research on medications contain only 'good news' — especially when the research is industry-funded When thousands of psychiatrists attend their field's largest annual meeting each year, the presentations they hear about research into drug treatments report overwhelmingly on positive results. That's the finding of a new study published in the Journal of Clinical Psychopharmacology by two young psychiatrists from the University of...

Chinese Herb Kudzu Reduces Consumption Of Alcohol
2012-05-18 10:29:30

According to a new study published in the current issue of Drug and Alcohol Dependence by McLean Hospital and Harvard Medical School researchers, an extract of the Chinese herb kudzu reduces binge drinking and could be useful in the treatment of alcoholism. David Penetar, PhD, lead author of the study from the Behavioral Psychopharmacology Research Laboratory at McLean Hospital, explains: “Our study is further evidence that components found in kudzu root can reduce alcohol...